• Atossa Therapeutics, Coronavirus, Overall Health

Dr. Quay Discusses Genetic Privacy, Public Health, and Future Pandemics on America at Night

Dr. Steven Quay was recently featured on the nationally syndicated program, “America at Night” with Rich Valdés. In this in-depth conversation, Dr. Quay shares evidence-based perspectives on the opportunities and challenges surrounding genetic privacy, advances in public health, and the urgent need for scientific policy reform.

Drawing on his decades of experience as a physician, scientist, and founder of Atossa Therapeutics, Dr. Quay addresses timely topics, including:

  • The implications of pharmaceutical companies acquiring large genetic data sets
  • The balance of benefits and risks in genetic testing
  • The growing role of lifestyle in chronic disease
  • The risks and ethical questions surrounding gain-of-function research
  • The potential long-term impact of high-lethality pathogens

Dr. Quay also emphasizes the importance of legislative safeguards and transparent communication to protect patients and improve outcomes for future generations.

For those interested in a deeper exploration of these issues, Dr. Quay’s upcoming book, The Code as Witness, provides a comprehensive scientific and legislative roadmap to prevent future pandemics. Preorder your copy on Amazon today.

  • Tags: America At Night, Atossa Therapeutics, book preorder, COVID-19, Dr. Steven Quay, gain of function research, genetic privacy, genetics, healthcare reform, pandemic prevention, podcast, public health, Rich Valdés, scientific policy, The Code as Witness

Steven Quay is the founder of Seattle-based Atossa Therapeutics Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other breast conditions.

He received his M.D. and Ph.D. from The University of Michigan, was a postdoctoral fellow at MIT with Nobel Laureate H. Gobind Khorana, a resident at the Harvard-MGH Hospital, and was on the faculty of Stanford University School of Medicine. His contributions to medicine have been cited over 9,600 times. He has founded six startups, invented seven FDA-approved pharmaceuticals, and holds 87 US patents. Over 80 million people have benefited from the medicines he invented.

His current passion is the prevention of the two million yearly breast cancer cases worldwide.

Related Content

Was the Nation Watching Side Effects Unfold? Dr. Quay Analyzes President Biden’s Health

May 21, 2025

Dr. Steven Quay joins Real America’s Voice to explore whether President Biden’s public health changes could reflect the side effects of prostate cancer treatment. Learn how early detection and treatment can affect cognitive and physical health, and why these questions matter for both patients and national leaders.

President Biden’s Prostate Cancer Diagnosis: What It Means for Patients, Families, and the Nation

May 19, 2025

Dr. Steven Quay joins Fox News to discuss President Biden’s advanced prostate cancer diagnosis, the importance of early detection, and what this means for patients and families. Learn more about the medical facts, treatment options, and why regular screening matters.

National Women’s Checkup Day: Dr. Steven Quay’s Health Advice for Women

May 18, 2025

On National Women’s Checkup Day, Dr. Steven Quay shares practical advice on the importance of regular checkups, early detection, and preventive care for women’s health. Watch Dr. Quay’s KFYR TV interview for tips on breast cancer prevention and staying healthy all year.

Join Dr. Quay’s ElevatorMedicine™ and get FREE, QUICK TIPS for better living, health, and wellness that take less time than riding an elevator!